Childhood Obesity research paper: Investigate pathopharmacological issues related to a specific disease process

Childhood Obesity research paper: Investigate pathopharmacological issues related to a specific disease process

For this assessment, you will investigate pathopharmacological issues related to a specific disease process. You may choose to investigate childhood obesity. As part of this assessment, you will analyze the various impacts the disease process has on the patients, their families, and populations at a local, national, and international level.

Requirements:
A. Investigate childhood obesity
1. Analyze the pathophysiology of the disease process you selected in part A.
2. Discuss the standard of practice for the selected disease process.
a. Discuss the evidence-based pharmacological treatments in the state of Pennsylvania and how they affect management of the selected disease in your community.
b. Discuss clinical guidelines for assessment, diagnosis, and patient education for the selected disease process.
c. Compare the standard practice for managing the disease within your community with state or national practices.
3. Discuss characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes.
a. Analyze disparities between management of the selected disease on a national and international level.
4. Discuss three or four factors (e.g., financial resources, access to care, insured/uninsured, Medicare/Medicaid) that contribute to a patient being able to manage the selected disease
a. Explain how a lack of the factors discussed in part A4 leads to an unmanaged disease process.
i. Describe characteristics of a patient with the selected disease that is unmanaged.

B. Analyze how the selected disease process affects patients, families, and populations in your community.
1. Discuss the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment.

C. Discuss how you will promote best practices for managing the selected disease in a healthcare organization.
1. Discuss three strategies you could use to implement best practices for managing the selected disease in a healthcare organization.
2. Discuss an appropriate method to evaluate the implementation of each of the strategies from part C1.

D. When you use sources, include all in-text citations and references in APA format.

Note: When using sources to support ideas and elements in an assessment, the submission MUST include APA formatted in-text citations with a corresponding reference list for any direct quotes or paraphrasing. It is not necessary to list sources that were consulted if they have not been quoted or paraphrased in the text of the assessment.

Note: No more than a combined total of 30% of a submission can be directly quoted or closely paraphrased from outside sources, even if cited correctly.

**Note: Paper submission will be ran through Turnitin a system that checks for plagiarism.
**Note: Include Headings with letters and title in paper as per rubric… example, A. Investigated Disease Process, A1. Pathophysiology, A2. Standard of Practice ext.
Rubric included below: follow Rubric as well as above instructions:
Articulation of Response (clarity, organization, mechanics)-provide substantial articulation of response.
A. Investigated Disease Process- investigates childhood obesity disease processes.
A1. Pathophysiology- provide a plausible analysis, with substantial detail, of the pathophysiology of the disease process selected in part A.
A2. Standard of Practice- provide a logical discussion, with substantial detail, of the standard of practice for the selected disease process.
A2a. Pharmacological Treatments- provide a logical discussion, with substantial detail, of the evidence-based pharmacological treatments in Pennsylvania and how they affect management of the selected disease in the community.
A2b. Clinical Guidelines-provides a logical discussion, with substantial detail, of clinical guidelines for assessment, diagnosis, and patient education for the selected disease process.
A2c. Standard Practice of Disease Management- provides an appropriate comparison, with substantial detail, of standard practice for managing the disease within the a community with state or national practices.
A3. Managed Disease Process- provide a logical discussion, with substantial detail, of characteristics of and resources for a patient who manages the selected disease well, including access to care, treatment options, life expectancy, and outcomes.
A3a. Disparities-provide a plausible analysis, with substantial support, of disparities between management of the selected disease on a national and international level.
A4. Managed Disease Factors-provide a logical discussion, with sufficient detail, of 3 or 4 factors that contribute to a patient being able to manage the selected disease.
A4a. Unmanaged Disease Factors-provide a logical explanation, with substantial detail, of how a lack of the factors discussed in part A4 leads to an unmanaged disease process.
A4ai. Unmanaged Disease Characteristics-provide an appropriate description, with sufficient detail, of the characteristics of a patient with the selected disease that is unmanaged.
B. Patients, Families, & Populations-provide a plausible analysis, with substantial detail, of how the selected disease process affects patients, families, and populations in the candidate’s community.
B1. Costs-provide a logical discussion, with substantial detail, of the financial costs associated with the selected disease process for patients, families, and populations from diagnosis to treatment.
C. Best Practices Promotion- provide a logical discussion, with substantial detail, of how to promote best practices for managing the selected disease in a healthcare organization.
C1. Implementation Plan- provide a logical discussion, with substantial detail, of 3 strategies the that could be used to implement best practices for managing the selected disease in a current healthcare organization.
C2. Evaluation Method- provides a logical discussion, with substantial detail, of an appropriate method to evaluate the implementation of each of the strategies from part C1.
D. Sources- provide appropriate in-text citations and references with no readily detectable deviations from APA style or use own wording

Looking for a similar assignment? Get help from our qualified experts!

Order Now

Related Posts